(Q33536291)

27 July 2017

1 reference

title

Anti-tumour activity of bisphosphonates in human myeloma cells. (English)

1 reference

27 July 2017

Shipman CM

1

1 reference

27 July 2017

Rogers MJ

2

1 reference

27 July 2017

Apperley JF

3

1 reference

27 July 2017

Graham R

4

1 reference

27 July 2017

Russell G

5

1 reference

27 July 2017

Croucher PI

6

1 reference

27 July 2017

publication date

1 December 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

32

1 reference

27 July 2017

issue

1-2

1 reference

27 July 2017

page(s)

129-138

1 reference

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bone-Resorbing Activity in Supernatants from Lymphoid Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

The management of Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Cell death: the significance of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809059253

10.3109/10428199809059253

21 January 2018

Identifiers

DOI

1 reference

release_l4fqy5jig5btzpfzdmpfwmswca

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l4fqy5jig5btzpfzdmpfwmswca

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference